tirzepatide weight loss roxbury STL Medical Weight Loss |

Additionally, a high percentage of participants achieved a weight reduction of 5% or more (85% with 5 mg, 89% with 10 mg, and 91% with 15 mg of tirzepatide)

Tirzepatide represents an important step in this direction, but further advances in triple agonism, oral formulations, and personalized medicine approaches will likely continue to reshape treatment paradigms

However, when combined with insulin or sulfonylureas, the risk increases

It activates both the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor

Serious but rare risks include hypoglycemia (low blood sugar), acute pancreatitis (severe, persistent abdominal pain often with vomiting), acute gallbladder disease (sudden right-upper abdominal pain that may radiate to the shoulder), non-arteritic anterior ischemic optic neuropathy (sudden, potentially permanent vision loss), mood changes, and severe allergic reactions with breathing difficulty or swelling of the lips, tongue, or throat